December 27, 2014 9:54 AM ET

Biotechnology

Company Overview of Ambrilia Biopharma, Inc.

Executive Profile

Robert Edward Hawkins M.B., B.S., Ph.D., F.R.C.P.

Former Member of Oncology Scientific Advisory Board, Ambrilia Biopharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Prof. Robert Edward Hawkins M.B., B.S., Ph.D., F.R.C.P. serves as Professor of Medical Oncology at the University of Manchester and Director of Cancer Research UK Programme focusing on development of new treatments for cancer. Prof. Hawkins also serves as Director of Medical Oncology and Honorary Consultant in Medical Oncology at the Christie Hospital in Manchester, England where he is managing and developing one of the largest Medical Oncology Departments in the UK. ...

Corporate Headquarters

1010 Sherbrooke Street
Montreal, Quebec H3A 2R7

Canada

Phone: 514-751-2003
Fax: 514-751-2502

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ambrilia Biopharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.